This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

EU Pharmaceutical Law Forum
Mark Your Calendar for EU Pharmaceutical Law Forum 2024!
May 21-23, 2024Steigenberger Wiltcher's, Brussels
Menu
keyboard_arrow_right

Day 2 - CET/CEST (Cent Europe Summer, GMT+2)

keyboard_arrow_leftSearch & Filter
search

Day 2 - CET/CEST (Cent Europe Summer, GMT+2)

search
Showing 1 of 1 Streams
08:50 - 09:00
Opening Remarks from Morning Chair
  • Eveline Van Keymeulen - Partner, Latham & Watkins LLP
09:00 - 09:30
KEYNOTE: EU Commission Update on the Regulatory Landscape
  • Florian Schmidt - Deputy Head of Unit, DG SANTE, European Commission, European Commission
09:30 - 10:30
KEYNOTE PANEL: Industry Impact the EU Pharmaceutical Legislation Revision
  • Stefano Marino - Head of Legal Services, European Medicines Agency
  • Florian Schmidt - Deputy Head of Unit, DG SANTE, European Commission, European Commission
  • Kristine Peers - General Counsel, European Federation of Pharmaceutical Industries and Associations (EFPIA)
  • Eveline Van Keymeulen - Partner, Latham & Watkins LLP
10:30 - 11:00
Networking Break
Showing 1 of 1 Streams
11:00 - 12:00
KEYNOTE PANEL: Detailed Review of Proposals for Incentivising R&D in Unmet Medical Needs: General Pharmaceutical Legislation, Orphan, and Paediatric Regulations
  • Peter Bogaert - Partner, Covington & Burling LLP
  • Georgia Gavriilidou - Associate General Counsel, Amgen
  • Victoria Kitcatt - VP & Assistant General Counsel, Pfizer
  • Elise Melon - Head of Policy, Strategy & Operations, Global Legal Affairs, UCB
12:00 - 12:40
DUAL DIALOGUE: New Obligations and Liability for your Supply Chain
  • Evi Mathiou - Legal, Compliance & Quality Director, Novo Nordisk
  • Peter L'Ecluse - Partner, Van Bael & Bellis LLP
12:40 - 14:00
Networking Lunch
Showing 1 of 1 Streams
14:00 - 14:10
Opening Remarks from Afternoon Chair
  • Christian Jervelund - Partner, Copenhagen Economics
14:10 - 15:10
PANEL: New HTA Regulations and Evolving Pharmaceutical Market Access Frameworks
  • Ansgar Hebborn - Head, European Access Policy Affairs, Roche
  • Christian Jervelund - Partner, Copenhagen Economics
  • Matthias Heck - Attorney-at-Law, Senior Director, International TA Policy Strategy, Alexion Astra Zeneca Rare Disease
  • Adela Williams - Partner, Arnold & Porter
15:10 - 15:50
TRI DIALOGUE: Regulatory Frameworks for Healthcare Systems Solutions and Market Access Strategies
  • Ilja Moree - Head Legal Europe Innovative Medicines, Novartis AG
  • Kirsten Broeckers - Vice President, Head Legal Affairs EMEA, Novartis Gene Therapies GmbH
  • Jordi Faus - Managing Partner, Faus Moliner
15:50 - 16:20
Networking Break
Showing 1 of 1 Streams
16:20 - 17:00
TRI DIALOGUE: The MDR and IVDR – Challenges and Opportunities
  • Hilary Jones - Senior Director, Legal Pharmaceutical Regulation, BioNTech UK Limited
  • Sophie Pelé - Regulatory Partner, Dechert LLP
  • Amelie Chollet - Legal Regulatory Counsel, EMEA, Abbott
17:00 - 17:40
DUAL DIALOGUE: Reshaping Clinical Research with Health Data
  • Martijn ten Bloemendal - Global Privacy Counsel, AbbVie
  • Tine Carmeliet - Senior Associate, Allen & Overy LLP
17:40 - 18:40
Close of Day Followed by Networking Drinks Reception
Day 1
NextDay 3
Filter
Streams
Formats
Choose Day